PCGEM1 and prostate cancer: Further research showed that cotransfection of a miR-506-3p inhibitor with a TRIAP1 overexpression plasmid restored the suppressive effect of PCGEM1 knockdown on the proliferation, migration and invasion of prostate cancer.